论文部分内容阅读
Objective:MicroRNA-21(miR-21)has been shown to be a key regulator of carcinogenesis.There were few reports about the comparison of serum miR-21 with conventional tumor markers.This study aimed to explore the diagnostic value of circulating miR-21 as a tumor marker in breast cancer(BC)and compare it with CA153 and carcinoembryonic antigen(CEA).Methods:Circulating miR-16 and miR-21 were amplified and quantitatively detected by real-time PCR in 89 BC patients and 55 healthy controls.The levels of CA153 and CEA were measured through electrochemiluminescence assays.Then the sensitivity in diagnosis of BC was compared among miR-21,CA153 and CEA.Results:The level of serum miR-21 was significantly higher in BC patients than controls(P<0.001).The sensitivity and specificity of miR-21 were 87.6%and 87.3%,respectively,whereas the sensitivities of CEA and CA153 were only 22.47%and 15.73%.Conclusions:Compared with CEA and CA153,serum miR-21 has a higher sensitivity in diagnosis of BC.Although not correlated with the status of ER,PR and clinical stages,serum miR-21 may be a potential diagnostic indicator for BC,especially for the early stage.
Objective: MicroRNA-21 (miR-21) has been shown to be a key regulator of carcinogenesis. There were few reports about the comparison of serum miR-21 with conventional tumor markers. This study aimed to explore the diagnostic value of circulating miR- 21 as a tumor marker in breast cancer (BC) and compare it with CA153 and carcinoembryonic antigen (CEA). Methods: Circulating miR-16 and miR-21 were amplified and quantitatively detected by real-time PCR in 89 BC patients and 55 healthy controls. these levels of CA153 and CEA were measured through electrochemiluminescence assays. Chen the sensitivity in diagnosis of BC was was among miR-21, CA153 and CEA. Results: The level of serum miR-21 was significantly higher in BC patients than controls ( P <0.001). Sensitivity and specificity of miR-21 were 87.6% and 87.3%, respectively, while the sensitivities of CEA and CA153 were only 22.47% and 15.73% .Conclusions: Compared with CEA and CA153, serum miR-21 has a higher sensitivity in diagnosis of BC.Although not c orrelated with the status of ER, PR and clinical stages, serum miR-21 may be a potential diagnostic indicator for BC, especially for the early stage.